Alterations of TME: Chemotherapy drugs foster a senescent phenotype in stromal fibroblasts, triggering metabolic shifts and the release of paracrine factors, activating tumor cell survival pathways such as ERK1/2 signaling pathways (139), and enhancing PCa cells invasiveness and clonogenic potential. The gene discussed is MAPK3; the disease is neoplasm.